ABN 81 077 771 987 30 th June 2026 Annual Report FY 2026 Optiscan Imaging Limited (ASX:OIL) is a global leader in the development, manufacturing, and commercialisation of imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time,...
2026 Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Optiscan Imaging Limited on 6ix
Story so far
Earlier from Optiscan Imaging
- Quarterly Activities/Appendix 4C Cash Flow Report
- Optiscan Signs New Research Agreement for Breast Study
- Head and Neck Study Progressing Ahead of Schedule
- Optiscan Launches InSpecta Device for Veterinary Medicine
- Halfway Mark Reached in Optiscan Breast Cancer Study
Later from Optiscan Imaging
- Appendix 4G & Corporate Governance Statement
- Preliminary Final Report
- Optiscan Initiates Head and Neck Cancer Study in the US
- Change of Director's Interest Notice
- Application for quotation of securities - OIL
Follow Optiscan Imaging into a list and get an email when it puts out news.
Follow Optiscan Imaging